XML 65 R10.htm IDEA: XBRL DOCUMENT v3.20.1
5. Supplemental Financial Information
9 Months Ended
Mar. 31, 2020
Supplemental Financial Information  
Supplemental Financial Information

5. Supplemental Financial Information

 

Inventories

 

Inventories are stated at the lower of cost (first-in, first-out) or net realizable value and consist of the following:

 

   March 31,   June 30, 
   2020   2019 
   (In thousands) 
Finished goods  $8,651   $6,084 
Raw materials   6,595    4,425 
Inventories, net  $15,246   $10,509 

 

Other Liabilities

 

The following table presents details of our other liabilities:

 

   March 31,   June 30, 
   2020   2019 
   (In thousands) 
Current          
Accrued variable consideration  $1,383   $1,313 
Customer deposits and refunds   250    168 
Accrued raw materials purchases   681    1,155 
Deferred revenue   725    328 
Lease liability   1,151    4 
Taxes payable   407    322 
Accrued operating expenses   2,090    1,290 
Total other current liabilities  $6,687   $4,580 
           
Non-current          
Lease liability  $1,473   $48 
Deferred revenue   158    158 
Total other non-current liabilities  $1,631   $206 

 

Computation of Net Income (Loss) per Share

 

Basic and diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the applicable period.

 

The following table presents the computation of net income (loss) per share:

 

   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2020   2019   2020   2019 
   (In thousands, except per share data) 
Numerator:                
Net income (loss)  $(5,216)  $857   $(9,037)  $1,051 
Denominator:                    
Weighted-average common shares outstanding - basic   27,048    22,270    24,369    21,237 
Effect of dilutive securities:       1,034        1,395 
Denominator for net income (loss) per share - diluted   27,048    23,304    24,369    22,632 
                     
Net income (loss) per share - basic  $(0.19)  $0.04   $(0.37)  $0.05 
Net income (loss) per share - diluted  $(0.19)  $0.04   $(0.37)  $0.05 

 

The following table presents the common stock equivalents excluded from the diluted net loss per share calculation, because they were anti-dilutive for the periods presented. These excluded common stock equivalents could be dilutive in the future.

 

   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2020   2019   2020   2019 
   (In thousands) 
                 
Common stock equivalents   1,487    153    1,640    66 

 

Severance and Related Charges

 

Current Fiscal Year

 

During the nine months ended March 31, 2020, we continued a plan to realign certain personnel resources to better fit our current business needs, which includes identifying cost savings and synergies to be gained from the acquisitions of Maestro and Intrinsyc. Additionally, the current year charges include costs incurred pursuant to change-in-control agreements for certain employees of Intrinsyc.

 

The following table presents details of the liability we recorded related to these activities:

 

   Nine Months Ended 
   March 31, 
   2020 
    (In thousands) 
Beginning balance  $651 
Charges   3,365 
Payments   (2,786)
Ending balance  $1,230 

 

The ending balance is recorded in accrued payroll and related expenses on the accompanying unaudited condensed consolidated balance sheet at March 31, 2020.

 

Prior Fiscal Year

 

During the nine months ended March 31, 2019, we incurred charges totaling approximately $323,000 in severance-related costs in connection with a plan to realign certain personnel and cost structure needs.

 

Supplemental Cash Flow Information

 

The following table presents non-cash investing transactions excluded from the accompanying unaudited condensed consolidated statements of cash flows:

 

   Nine Months Ended 
   March 31, 
   2020   2019 
   (In thousands) 
Share consideration for acquisition of Intrinsyc  $15,574    $ 
Accrued property and equipment paid for in the subsequent period  $5   $276 
Accrued stock option exercise proceeds  $   $97